Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study

Cephalalgia : an International Journal of Headache
Paolo RossiGiuseppe Nappi

Abstract

The aim of this study was to evaluate the rates and predictors of relapse, after successful drug withdrawal, in migraine patients with medication overuse headache (MOH) and low medical needs. The study population, study design, inclusion criteria and short-term effectiveness of the medication withdrawal strategies have been described elsewhere (Rossi et al., Cephalalgia 2006; 26:1097). Relapsers were defined as those patients fulfilling, at follow-up, the new International Classification of Headache Disorders, 2nd edn, appendix criteria for MOH. Complete datasets were available for 83 patients. At 1 year's follow up, the relapse rate was 20.5%. Univariate analysis showed that patients who relapsed had a longer duration of migraine with more than eight headache days/month, a longer duration of drug overuse, had tried a greater number of preventive treatments in the past, had a lower reduction of headache frequency after withdrawal, and had previously consulted a greater number of specialists. Binary logistic regression analysis was performed, and three variables emerged as significant predictors of relapse: duration of migraine with more than eight headache days/month [odds ratio (OR) 1.57, P = 0.01], a higher frequency of migra...Continue Reading

References

Apr 1, 1999·Cephalalgia : an International Journal of Headache·B SuhrI W Husstedt
Sep 5, 2001·Cephalalgia : an International Journal of Headache·G G TriblP Wessely
Dec 21, 2004·Cephalalgia : an International Journal of Headache·Z KatsaravaV Limmroth
May 25, 2005·Cephalalgia : an International Journal of Headache·S D SilbersteinUNKNOWN International Headache Society
Jun 16, 2005·Cephalalgia : an International Journal of Headache·J R SaperA E Lake
May 12, 2006·Cephalalgia : an International Journal of Headache·UNKNOWN Headache Classification CommitteeT J Steiner
Mar 16, 2007·Headache·Anna FerrariEmilio Sternieri
May 15, 2007·Current Opinion in Neurology·Zaza Katsarava, Rigmor Jensen
Sep 25, 2007·Cephalalgia : an International Journal of Headache·J Zidverc-TrajkovicN Sternic

❮ Previous
Next ❯

Citations

May 25, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·O GambiniG Bussone
Nov 30, 2011·Current Pain and Headache Reports·Jong-Ling Fuh, Shuu-Jiun Wang
Aug 9, 2013·CNS Drugs·Joel R Saper, Arnaldo Neves Da Silva
Aug 13, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S EversUNKNOWN European Federation of Neurological Societies
May 15, 2009·Cephalalgia : an International Journal of Headache·L S GudmundssonV Gudnason
Jul 21, 2009·Cephalalgia : an International Journal of Headache·F AndrasikG Bussone
Aug 28, 2014·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Wen FanJiying Zhou
May 21, 2015·BMC Neurology·Stefano CaproniUNKNOWN SAMOHA Study Group
Jun 28, 2011·Cephalalgia : an International Journal of Headache·C Créac'hM Navez
Aug 2, 2014·Therapeutic Advances in Drug Safety·Espen Saxhaug Kristoffersen, Christofer Lundqvist
Jul 6, 2014·Headache·Signe B Munksgaard, Rigmor H Jensen
Dec 30, 2014·Headache·Signe B Munksgaard, Rigmor H Jensen
Oct 6, 2009·The Journal of Headache and Pain·Paolo RossiUNKNOWN COMOESTAS Consortium
Sep 23, 2011·The Journal of Headache and Pain·Andrea Negro, Paolo Martelletti
May 18, 2010·The Journal of Headache and Pain·Knut HagenLars Jacob Stovner
May 21, 2017·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Alberto RaggiDomenico D'Amico
Dec 13, 2016·Cephalalgia : an International Journal of Headache·Jasna J Zidverc-TrajkovicNadezda Sternic
Feb 28, 2013·Cephalalgia : an International Journal of Headache·Grazia SancesCristina Tassorelli
Jul 1, 2015·Cephalalgia : an International Journal of Headache·Chia-Chun ChiangDavid W Dodick
Mar 27, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·I CorbelliUNKNOWN SAMOHA Study Group
Jul 22, 2016·Cephalalgia : an International Journal of Headache·Cristina TassorelliUNKNOWN COMOESTAS Consortium
Feb 3, 2019·Acta Neurologica Scandinavica·Signe B MunksgaardTroels Wienecke
May 21, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H C DienerJ A Petersen
Aug 21, 2020·Cephalalgia : an International Journal of Headache·Kati ToomZara Katsarava
Jun 26, 2012·Headache·Signe B MunksgaardRigmor H Jensen
May 11, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E S KristoffersenC Lundqvist
Apr 2, 2020·Headache·Nicolas VandenbusscheZaza Katsarava
Aug 16, 2017·Current Treatment Options in Neurology·Andrea NegroPaolo Martelletti
Jul 4, 2015·Current Treatment Options in Neurology·Maria Adele GiamberardinoPaolo Martelletti
Aug 1, 2019·Arquivos de neuro-psiquiatria·Fernando KowacsMauro Eduardo Jurno
Apr 4, 2017·Acta Neurologica Scandinavica·E S KristoffersenC Lundqvist
Feb 7, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Maria Michela CainazzoSimona Guerzoni
Apr 30, 2021·The Journal of Headache and Pain·Tatiane Teru TakahashiUNKNOWN European Headache Federation School of Advanced Studies (EHF-SAS)
May 19, 2021·CNS Drugs·Christina Sun-EdelsteinAnan Srikiatkhachorn
May 27, 2021·Acta Neurologica Scandinavica·Domenico D'AmicoAlberto Raggi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.